CAS NO: | 408504-26-7 |
包装 | 价格(元) |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
生物活性 |
Sergliflozin etabonate (GW-869682X) is a potent and orally activesodium glucose cotransporter (SGLT2)inhibitor. Sergliflozin etabonate shows antidiabetic and antihyperglycemic effects. Sergliflozin etabonate significantly reduces non-fasting blood glucose levels in diabetic mice. Sergliflozin etabonate has the potential for the research of diabetes[1]. |
||||||||||||||||
IC50& Target[1] |
|
||||||||||||||||
体内研究 (In Vivo) |
Sergliflozin etabonate (1、3、10、30 mg/kg;口服;一次) 以剂量依赖性方式显着降低 KK-Ay 小鼠的非空腹血糖水平[1]。
|
||||||||||||||||
分子量 |
448.46 |
||||||||||||||||
Formula |
C23H28O9 |
||||||||||||||||
CAS 号 |
408504-26-7 |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
Please store the product under the recommended conditions in the Certificate of Analysis. |